Vildagliptin reduces specific TG species in T2D; GLP-1 blockade increases total TGs
Photo by Cht Gsml / Unsplash
Key Takeaway
Interpret small study on vildagliptin and TG species as preliminary physiological insight, not clinical guidance.
This randomized controlled trial examined the acute physiological effects of DPP-4 inhibition and GLP-1 receptor blockade on postprandial lipid metabolism. The study enrolled 15 participants with type 2 diabetes managed by diet and/or metformin. Participants received either vildagliptin (50 mg orally) followed by intravenous exendin(9-39) or saline, or placebo orally followed by intravenous saline, during intraduodenal lipid emulsion infusion and a mixed meal.
Treatment with vildagliptin alone reduced plasma concentrations of two specific triglyceride species: TG(54:4) and TG(54:5), both with P < 0.01. However, when endogenous GLP-1 was blocked with exendin(9-39) during vildagliptin treatment, total plasma triglycerides increased significantly (P < 0.001). Furthermore, 10 individual triglyceride species were elevated during this combined treatment, each with P < 0.05.
Safety and tolerability data were not reported. The study's key limitations include its very small sample size (n=15), short-term physiological design, and focus on surrogate lipid outcomes rather than clinical endpoints. The population was specific to patients managed with diet and/or metformin only.
For practice, this study provides mechanistic insight suggesting endogenous GLP-1 contributes to modulating postprandial triglyceride appearance during DPP-4 inhibition. However, it does not establish causation for clinical outcomes like cardiovascular risk. The findings are preliminary and require validation in larger, longer-term studies with clinical endpoints before any practice implications can be drawn.
More on Type 2 Diabetes
Review of NHANES data links metformin use to lower mortality and inflammatory markers in type 2 diabetes
Metformin use linked to lower death risk and better inflammation markers in U.S. adults with diabetes
This review of NHANES 2013-2018 data (2,116 adults) found that metformin use was associated with lower all-cause and cardiovascular mortalit…
New analysis of U.S. adults with diabetes suggests metformin use connects to lower death risk and improved inflammation markers, though more…
A 1-month nudge-based dietary intervention increased daily step counts by 1105 steps at 3 months in adults with type 2 diabetes.
Small diet changes might boost steps for a short time in diabetes care
This cluster-randomised controlled trial enrolled 204 adults aged 18-59 years with type 2 diabetes across 12 primary healthcare centres in B…
A simple diet plan helped people with diabetes walk more for three months but the extra steps did not stick in the long run
Mobile app plus group sessions showed feasibility in Malaysian women with gestational diabetes
A new app plus support for diabetes care in Malaysia showed no benefit yet.
This feasibility randomized controlled trial enrolled 60 women with gestational diabetes mellitus in Malaysia. The intervention included mob…
A trial in Malaysia found that a mobile app and group sessions did not improve health outcomes for women with gestational diabetes compared …
Oral Sodium Butyrate Reduces Weight in Overweight Adults Without Diabetes
Oral sodium butyrate helps overweight adults without diabetes lose weight
This 12-week proof-of-concept RCT in 46 overweight adults (23 with type 2 diabetes) found that oral sodium butyrate 1875 mg/day led to great…
A new trial shows oral sodium butyrate helps adults without diabetes lose more weight than a placebo over three months.
View Original Abstract ↓
UNLABELLED: Glucagon-like peptide 1 (GLP-1) receptor agonists improve dyslipidemia and reduce cardiovascular risk in type 2 diabetes (T2D), but the role of endogenous GLP-1 in lipid metabolism remains unclear. We evaluated the effect of dipeptidyl peptidase 4 (DPP-4) inhibition on the response of plasma triglycerides (TGs) to intraduodenal lipid and a mixed meal, and the impact of GLP-1 receptor blockade with exendin(9-39) in T2D. Fifteen participants with T2D, managed by diet and/or metformin, were studied on three occasions in a double-blind, randomized, crossover design. Vildagliptin (50 mg) or placebo was administered orally (t = -60 min), followed by intravenous exendin(9-39) from t = -60 to 150 min on one of the two vildagliptin days or 0.9% saline on two other days. A lipid emulsion was infused intraduodenally (2 kcal/min, t = 0-120 min), followed by a mixed meal (t = 120-150 min). Plasma TG levels, quantified by liquid chromatography-tandem mass spectrometry, increased after lipid and meal, with most individual TGs corresponding to those in the lipid emulsion. Vildagliptin reduced TG(54:4) and TG(54:5) concentrations (each P < 0.01), without affecting total TGs. Blocking endogenous GLP-1 during vildagliptin treatment increased plasma total TGs (P < 0.001), associated with elevations of 10 individual TG species (P < 0.05 each). These outcomes suggest that endogenous GLP-1 contributes to the physiological modulation of postprandial TG appearance in T2D.
ARTICLE HIGHLIGHTS: The contribution of endogenous glucagon-like peptide 1 (GLP-1) to postprandial lipid metabolism in type 2 diabetes (T2D) is poorly defined. The specific questions we wanted to answer were what is the effect of dipeptidyl peptidase 4 (DPP-4) inhibition on plasma triglyceride (TG) profiles during an intraduodenal lipid infusion and following a mixed meal in T2D, and how does blockage of endogenous GLP-1 signaling affect these responses? We found that plasma TGs increased after intraduodenal lipid infusion and the meal, with most species reflecting the infused lipid emulsion. Vildagliptin selectively reduced TG(54:4) and TG(54:5) species, whereas exendin(9-39) increased total TGs and 10 individual TG species. The implications of our finding are that endogenous GLP-1 plays a physiological role in the regulation of postprandial lipid handling in T2D.
Meta-analysis finds distinct neural activation patterns to food and monetary rewards in overweight/obesity
Brain scans reveal how food and money rewards differ in people with overweight or obesity
Related in Nutrition & Obesity Medicine
Observational study finds Touch Activated Phlebotomy reduces pain in autistic and non-autistic adults compared to traditional venipuncture
Touch Activated Phlebotomy Causes Less Pain Than Traditional Blood Draws
This primary research article reports on an observational study of 23 participants, including 11 autistic adults and 12 non-autistic adults.…
A small study found a new blood draw device caused less pain than standard methods for both autistic and non-autistic adults.
TMAO levels and clinical variables associated with poor outcomes in acute ischemic stroke
Gut-derived TMAO linked to poor stroke recovery outcomes
This retrospective case-control study of 213 patients with acute ischemic stroke undergoing endovascular therapy investigated associations w…
High levels of a gut-related compound may predict how well patients recover after an emergency procedure for an ischemic stroke.
Simplified protocol improves recovery rates and reduces costs for acute malnutrition in Venezuelan children
A New Way to Treat Child Malnutrition Saves Money
This prospective cohort study compared a simplified protocol against WHO standard guidelines in 229 children aged 6-59 months with acute mal…
A new treatment plan for malnourished children in Venezuela costs less and helps more kids recover without losing safety or speed.
Plasma homocysteine levels associated with increased risk of incident metabolic dysfunction-associated steatotic liver disease
High or low homocysteine levels raise your liver disease risk
This cohort study included 5,184 adults from the Dalian Health Management Cohort. Researchers found a positive association between plasma ho…
Both very high and very low homocysteine levels could increase your risk of developing fatty liver disease in the future.
From Other Specialties
Systematic review and meta-analysis shows cefotiam reduces postoperative infection in clean surgery
Cefotiam cuts post-surgery infection risk by half compared to no antibiotics
This systematic review and meta-analysis evaluated cefotiam prophylaxis versus no antibiotic prophylaxis or other beta-lactam agents in adul…
A large review found cefotiam lowers infection risk after clean surgery. It works as well as other common antibiotics without causing more s…
Therapeutic Touch Reduces Crying and Improves Sleep in Infants With Colic
Therapeutic touch reduces crying in babies with colic
This randomized controlled trial in 96 infants with colic found that therapeutic touch based on Watson's Human Care Theory significantly red…
A new trial shows gentle therapeutic touch helps babies cry less and sleep better when they have infantile colic.
Mycophenolate mofetil non-inferior to prednisone for first-episode nephrotic syndrome in children
Mycophenolate Mofetil Offers Alternative to Steroids for Nephrotic Syndrome
This phase 3 non-inferiority trial randomized 272 children aged 1-10 years with first-episode steroid-sensitive nephrotic syndrome to mycoph…
A new trial shows mycophenolate mofetil works as well as prednisone for children with nephrotic syndrome, with fewer steroid side effects.
AquOTic water competency intervention improves outcomes in children with autism
Water therapy improves skills for children with autism spectrum disorder
This pre-post cohort study of 37 children with autism ages 5 to 9 found that a 10-week occupational therapy-based water competency intervent…
A water-based occupational therapy program significantly improved performance and satisfaction scores in children with autism spectrum disor…